Organization Overview
Alternative names
aminocaproic acid (amicar) (2 trials)
arsenic trioxide (trisenox) (1 trial)
autologous bone marrow derived mesenchymal cells (1 trial)
eltrombopag (promacta) (2 trials)
hydroxyurea (hydrea) (1 trial)
ibrutinib (imbruvica) (1 trial)
Amyotrophic Lateral Sclerosis (Phase 3)
Anemia (Phase 4)
Anemia, Hemolytic (Phase 3)
Anemia, Hemolytic, Autoimmune (Phase 3)
Anemia, Megaloblastic (Phase 4)
Anemia, Pernicious (Phase 4)
Anxiety Disorders (Phase 2)
Asthma (Phase 3)
Avitaminosis (Phase 4)
Blood Loss, Surgical (Phase 2)
Burns (Phase 2)
Bursitis (Phase 2)
Cerebral Palsy (Phase 2)
Chikungunya Fever (Phase 1)
Coronavirus Infections (Phase 3)
Dementia (Phase 4)
Diabetes Mellitus (Phase 4)
Disease (Phase 2)
Fasciitis (Phase 1)
Fasciitis, Plantar (Phase 1)
Fibromyalgia (Phase 4)
Graft vs Host Disease (Phase 2)
Hemolysis (Phase 3)
Hemorrhage (Phase 4)
Hodgkin Disease (Phase 2)
Hyperglycemia (Phase 4)
Hypothyroidism (Phase 3)
Leukemia (Phase 4)
Leukemia, Myeloid (Phase 4)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Metabolic Syndrome (Phase 3)
Motor Neuron Disease (Phase 3)
Myofascial Pain Syndromes (Phase 4)
Osteoarthritis (Phase 1)
Osteoarthritis, Knee (Phase 2)
Paralysis (Phase 2)
Patellofemoral Pain Syndrome (Phase 4)
Pneumonia (Phase 2)
Postpartum Hemorrhage (Phase 4)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 2)
Sclerosis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Sleep Wake Disorders (Phase 4)
Somatoform Disorders (Phase 4)
Syndrome (Phase 4)
Thrombocytopenia (Phase 2)
Thrombosis (Phase 2)
Vitamin D Deficiency (Phase 4)